Table 5

Findings of CFR in some diseases associated to coronary microvascular dysfunction and in healthy controls [36]

Clinical setting
CFR

Hypertrophic cardiomyopathy
2.21 ± 0.2
Dilated cardiomyopathy
1.9 ± 0.2
Syndrome X
2.27 ± 0,3
Control group
3.3 ± 0.3

Dimitrow et al. Cardiovascular Ultrasound 2005 3:18   doi:10.1186/1476-7120-3-18